DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
"Worldly wisdom teaches that it is better for reputation to fail conventionally than to succeed unconventionally." ~John Maynard Keynes.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Alethea Fulcrum Fund, LP | 2019 | Mature | n/a | $41.4M | 0 |
| Alethea Medtech Fund, LP | 2018 | Harvest | n/a | $5.4M | 0 |
| Alethea Biotech Fund II, LP | 2017 | Wound down | n/a | $0 | 0 |
| Alethea Biotech Fund, LP | 2014 | Wound down | n/a | $7.6M | 0 |
Also named here, with no published line of their own (reach them through the firm): Tony Nmn Hsu (Managing Member / Chief Compliance Officer), Jennifer Lynn Hsu (Member).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan